Translating Science Into Clinical Practice: Guideline Optimization

ACC Guidelines App

New ACC and American Heart Association (AHA) guidelines on topics ranging from primary prevention to valvular heart disease will be the focus of a series of sessions at ACC.23/WCC, featuring guideline committee members and other leading experts.

Over the course of the last several years, the ACC has worked alongside AHA to optimize the clinical guideline process from pre-production review through to final dissemination, with the goal of creating guidelines that are more concise, timely, accessible, patient-centered and applicable to clinicians worldwide. In the last three years, six guidelines have been released, with the most recent from 2022 focused on aortic disease and heart failure.

ACC.23/WCC sessions will provide deep dives and discussion around these newest guidelines, with opportunities for interactive discussions on how to implement, optimize and translate recommendations into clinical practice.

Access all the ACC/AHA guidelines and related tools and resources at

Click here for a complete list of sessions, dates and times for the following ACC/AHA guidelines:

  • 2022 ACC/AHA Guideline For the Diagnosis and Management of Aortic Disease
  • 2022 AHA/ACC/HFSA Guideline For the Management of Heart Failure
  • 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline For the Evaluation and Diagnosis of Chest Pain
  • 2021 ACC/AHA/SCAI Guideline For Coronary Artery Revascularization
  • 2020 ACC/AHA Guideline For the Management of Patients With Valvular Heart Disease
  • 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease

Clinical Topics: Valvular Heart Disease, Vascular Medicine

Keywords: ACC23, ACC Annual Scientific Session, ACC Scientific Session Newspaper, ACC.23/WCC Meeting Newspaper, Heart Valve Diseases, Aortic Diseases

< Back to Listings